According to Altimmune's latest financial reports the company's current EPS (TTM) is -$1.63. In 2022 the company made an earnings per share (EPS) of -$1.77 an increase over its 2021 EPS that were of -$2.36.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.63 | -7.91% |
2022 | -$1.77 | -25% |
2021 | -$2.36 | 23.56% |
2020 | -$1.91 | 25.66% |
2019 | -$1.52 | -93.18% |
2018 | -$22.30 | -78.95% |
2017 | -$105.92 | 117.94% |
2016 | -$48.60 | 170% |
2015 | -$18.00 | -64.71% |
2014 | -$51.00 | -22.73% |
2013 | -$66.00 | 110.68% |
2012 | -$31.33 | 49.18% |
2011 | -$21.00 | -93.64% |
2010 | -$330.00 | -5.98% |
2009 | -$351.00 | -26.88% |
2008 | -$480.00 | -79.61% |
2007 | -$2,354 | -61.5% |
2006 | -$6,114 |